For research use only. Not for therapeutic Use.
VHL-IN-1 (CAT: I040720) is a potent and selective inhibitor of the von Hippel-Lindau (VHL) E3 ubiquitin ligase complex, with a dissociation constant (K<sub>d</sub>) of 37 nM. By disrupting the interaction between VHL and HIF-1α, VHL-IN-1 effectively stabilizes HIF-1α and enhances its transcriptional activity, making it a valuable tool in hypoxia-related research. Additionally, VHL-IN-1 serves as a chemical scaffold in the development of PROTACs (proteolysis-targeting chimeras), where it can be employed to recruit VHL for targeted protein degradation. This compound holds significant promise in cancer biology, oxygen sensing, and therapeutic targeting.
| CAS Number | 3033117-53-9 |
| Synonyms | (2S,4R)-1-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[2-methyl-4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide |
| Molecular Formula | C28H37FN4O4S |
| Purity | ≥95% |
| IUPAC Name | (2S,4R)-1-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[2-methyl-4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide |
| InChI | InChI=1S/C28H37FN4O4S/c1-15-11-18(22-17(3)30-14-38-22)7-8-20(15)16(2)31-24(35)21-12-19(34)13-33(21)25(36)23(27(4,5)6)32-26(37)28(29)9-10-28/h7-8,11,14,16,19,21,23,34H,9-10,12-13H2,1-6H3,(H,31,35)(H,32,37)/t16-,19+,21-,23+/m0/s1 |
| InChIKey | NBHYPBDUODSQHJ-DTPUHQDNSA-N |
| SMILES | CC1=C(C=CC(=C1)C2=C(N=CS2)C)C(C)NC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)C4(CC4)F)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
